Unsaturated androstanes which are substituted with one or more hydroxyl groups in any position in the ring system.
Thiohydantoin benzene derivative.
A microsomal cytochrome P450 enzyme that catalyzes the 17-alpha-hydroxylation of progesterone or pregnenolone and subsequent cleavage of the residual two carbons at C17 in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP17 gene, generates precursors for glucocorticoid, androgen, and estrogen synthesis. Defects in CYP17 gene cause congenital adrenal hyperplasia (ADRENAL HYPERPLASIA, CONGENITAL) and abnormal sexual differentiation.
The surgical removal of one or both testicles.
Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.
Compounds which inhibit or antagonize the biosynthesis or actions of androgens.
Tumors or cancer of the PROSTATE.
Surgical removal or artificial destruction of gonads.
Derivatives of the steroid androstane having two double bonds at any site in any of the rings.
Derivatives of ACETIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxymethane structure.
Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power.
A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer.
Certain tumors that 1, arise in organs that are normally dependent on specific hormones and 2, are stimulated or caused to regress by manipulation of the endocrine environment.
A group of diterpenoid CYCLODECANES named for the taxanes that were discovered in the TAXUS tree. The action on MICROTUBULES has made some of them useful as ANTINEOPLASTIC AGENTS.
Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079)
A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
Substances that inhibit or prevent the proliferation of NEOPLASMS.
Proteins, generally found in the CYTOPLASM, that specifically bind ANDROGENS and mediate their cellular actions. The complex of the androgen and receptor migrates to the CELL NUCLEUS where it induces transcription of specific segments of DNA.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Compounds that bind to and inhibit the activation of ANDROGEN RECEPTORS.
A phorbol ester found in CROTON OIL with very effective tumor promoting activity. It stimulates the synthesis of both DNA and RNA.
Sets of enzymatic reactions occurring in organisms and that form biochemicals by making new covalent bonds.
Preparations made from animal tissues or organs (ANIMAL STRUCTURES). They usually contain many components, any one of which may be pharmacologically or physiologically active. Tissue extracts may contain specific, but uncharacterized factors or proteins with specific actions.
Works about comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries.
Detailed financial plans for carrying out specific activities for a certain period of time. They include proposed income and expenditures.
Resistance or diminished response of a neoplasm to an antineoplastic agent in humans, animals, or cell or tissue cultures.
An enzyme that catalyzes reversibly the phosphorylation of acetate in the presence of a divalent cation and ATP with the formation of acetylphosphate and ADP. It is important in the glycolysis process. EC 2.7.2.1.
A potent androgenic metabolite of TESTOSTERONE. It is produced by the action of the enzyme 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE.
Works containing information articles on subjects in every field of knowledge, usually arranged in alphabetical order, or a similar work limited to a special field or subject. (From The ALA Glossary of Library and Information Science, 1983)
Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients.

Androstenols are a type of steroid compound that is found in both animals and humans. They are classified as pheromones, which are chemicals that can affect the behavior or physiology of other members of the same species. Androstenols are found in high concentrations in male sweat, and they have been suggested to play a role in human sexual attraction and communication.

In particular, androstenols are thought to have a positive and calming effect on people, and may help to reduce stress and anxiety. They have also been shown to increase feelings of approachability and friendliness between individuals. Some studies have suggested that androstenols may be particularly effective at enhancing social interactions in women.

Androstenols are often used in perfumes and colognes, as well as in aromatherapy products, because of their potential to promote positive social interactions and reduce stress. However, it is important to note that the effects of androstenols on human behavior and physiology are still not fully understood, and more research is needed to confirm their role in human communication and attraction.

Phenytoin is an anticonvulsant drug, which is chemically classified as a hydantoin. The term "phenylthiohydantoin" refers to the functional group that makes up the core structure of phenytoin and other related compounds. This group consists of a phenyl ring (a benzene ring with a hydrogen atom replaced by a hydrocarbon group) attached to a thiocarbonyl group (-C=S), which is in turn attached to a hydantoin ring.

The hydantoin ring is a six-membered ring containing two nitrogen atoms and two carbonyl groups, which makes it a cyclic urea derivative. Phenytoin's chemical formula is C15H14N2O2S, and its molecular structure can be represented as follows:

![Phenytoin Molecular Structure](https://www.researchgate.net/profile/Mohamed-Abdelkader-Elshaer-3/publication/327516849/figure/fig1/AS:616830886369744@1524486833308/Schematic-representation-of-phenytoin-structure.png)

Phenytoin is primarily used as an antiepileptic drug to control tonic-clonic (grand mal) and complex partial seizures. It works by stabilizing the inactive state of voltage-gated sodium channels in the brain, which reduces their excitability and helps prevent abnormal electrical activity leading to seizures.

In a medical context, "phenylthiohydantoin" is not typically used as a standalone definition but rather refers to the core structure of phenytoin and related compounds.

Steroid 17-alpha-hydroxylase, also known as CYP17A1, is a cytochrome P450 enzyme that plays a crucial role in steroid hormone biosynthesis. It is located in the endoplasmic reticulum of cells in the adrenal glands and gonads. This enzyme catalyzes the 17-alpha-hydroxylation and subsequent lyase cleavage of pregnenolone and progesterone, converting them into dehydroepiandrosterone (DHEA) and androstenedione, respectively. These steroid intermediates are essential for the biosynthesis of both glucocorticoids and sex steroids, including cortisol, aldosterone, estrogens, and testosterone.

Defects in the CYP17A1 gene can lead to several disorders, such as congenital adrenal hyperplasia (CAH) due to 17-alpha-hydroxylase deficiency, which is characterized by decreased production of cortisol and sex steroids and increased mineralocorticoid levels. This condition results in sexual infantilism, electrolyte imbalances, and hypertension.

Orchiectomy is a surgical procedure where one or both of the testicles are removed. It is also known as castration. This procedure can be performed for various reasons, including the treatment of testicular cancer, prostate cancer, or other conditions that may affect the testicles. It can also be done to reduce levels of male hormones in the body, such as in the case of transgender women undergoing gender affirming surgery. The specific medical definition may vary slightly depending on the context and the extent of the procedure.

Castration-resistant prostate cancer (CRPC) is a more advanced form of prostate cancer that no longer responds to treatments that lower levels of male hormones, such as orchiectomy (surgical removal of the testicles) or medical castration with luteinizing hormone-releasing hormone (LHRH) agonists or antagonists. Despite these interventions, the cancer continues to progress and grow. This is often due to the development of mechanisms that allow the cancer cells to produce their own male hormones or become less dependent on them for growth and survival. CRPC is a complex and heterogeneous disease with various clinical manifestations and treatment options, which may include chemotherapy, novel hormonal therapies, immunotherapy, and/or radiation therapy.

Androgen antagonists are a class of drugs that block the action of androgens, which are hormones that contribute to male sexual development and characteristics. They work by binding to androgen receptors in cells, preventing the natural androgens from attaching and exerting their effects. This can be useful in treating conditions that are caused or worsened by androgens, such as prostate cancer, hirsutism (excessive hair growth in women), and acne. Examples of androgen antagonists include flutamide, bicalutamide, and spironolactone.

Prostatic neoplasms refer to abnormal growths in the prostate gland, which can be benign or malignant. The term "neoplasm" simply means new or abnormal tissue growth. When it comes to the prostate, neoplasms are often referred to as tumors.

Benign prostatic neoplasms, such as prostate adenomas, are non-cancerous overgrowths of prostate tissue. They usually grow slowly and do not spread to other parts of the body. While they can cause uncomfortable symptoms like difficulty urinating, they are generally not life-threatening.

Malignant prostatic neoplasms, on the other hand, are cancerous growths. The most common type of prostate cancer is adenocarcinoma, which arises from the glandular cells in the prostate. Prostate cancer often grows slowly and may not cause any symptoms for many years. However, some types of prostate cancer can be aggressive and spread quickly to other parts of the body, such as the bones or lymph nodes.

It's important to note that while prostate neoplasms can be concerning, early detection and treatment can significantly improve outcomes for many men. Regular check-ups with a healthcare provider are key to monitoring prostate health and catching any potential issues early on.

Castration is a surgical procedure to remove the testicles in males or ovaries in females. In males, it is also known as orchiectomy. This procedure results in the inability to produce sex hormones and gametes (sperm in men and eggs in women), and can be done for various reasons such as medical treatment for certain types of cancer, to reduce sexual urges in individuals with criminal tendencies, or as a form of birth control in animals.

Androstadienes are a class of steroid hormones that are derived from androstenedione, which is a weak male sex hormone. Androstadienes include various compounds such as androstadiene-3,17-dione and androstanedione, which are intermediate products in the biosynthesis of more potent androgens like testosterone and dihydrotestosterone.

Androstadienes are present in both males and females but are found in higher concentrations in men. They can be detected in various bodily fluids, including blood, urine, sweat, and semen. In addition to their role in steroid hormone synthesis, androstadienes have been studied for their potential use as biomarkers of physiological processes and disease states.

It's worth noting that androstadienes are sometimes referred to as "androstenes" in the literature, although this term can also refer to other related compounds.

Acetates, in a medical context, most commonly refer to compounds that contain the acetate group, which is an functional group consisting of a carbon atom bonded to two hydrogen atoms and an oxygen atom (-COO-). An example of an acetate is sodium acetate (CH3COONa), which is a salt formed from acetic acid (CH3COOH) and is often used as a buffering agent in medical solutions.

Acetates can also refer to a group of medications that contain acetate as an active ingredient, such as magnesium acetate, which is used as a laxative, or calcium acetate, which is used to treat high levels of phosphate in the blood.

In addition, acetates can also refer to a process called acetylation, which is the addition of an acetyl group (-COCH3) to a molecule. This process can be important in the metabolism and regulation of various substances within the body.

Androgens are a class of hormones that are primarily responsible for the development and maintenance of male sexual characteristics and reproductive function. Testosterone is the most well-known androgen, but other androgens include dehydroepiandrosterone (DHEA), androstenedione, and dihydrotestosterone (DHT).

Androgens are produced primarily by the testes in men and the ovaries in women, although small amounts are also produced by the adrenal glands in both sexes. They play a critical role in the development of male secondary sexual characteristics during puberty, such as the growth of facial hair, deepening of the voice, and increased muscle mass.

In addition to their role in sexual development and function, androgens also have important effects on bone density, mood, and cognitive function. Abnormal levels of androgens can contribute to a variety of medical conditions, including infertility, erectile dysfunction, acne, hirsutism (excessive hair growth), and prostate cancer.

Prostate-Specific Antigen (PSA) is a glycoprotein enzyme produced by the epithelial cells of the prostate gland. It is primarily involved in liquefying semen after ejaculation, allowing sperm mobility.

In clinical medicine, PSA is used as a tumor marker, mainly for monitoring the treatment and recurrence of prostate cancer. Elevated levels of PSA can indicate inflammation, infection, benign prostatic hyperplasia (BPH), or prostate cancer. However, it's important to note that an elevated PSA level does not necessarily confirm cancer; further diagnostic tests like digital rectal examination, transrectal ultrasound, and prostate biopsy are often required for definitive diagnosis.

Doctors may also use PSA isoforms or derivatives, such as free PSA, total PSA, and PSA density, to help improve the specificity of cancer detection and differentiate between malignant and benign conditions.

Hormone-dependent neoplasms are a type of tumor that requires the presence of specific hormones to grow and multiply. These neoplasms have receptors on their cell surfaces that bind to the hormones, leading to the activation of signaling pathways that promote cell division and growth.

Examples of hormone-dependent neoplasms include breast cancer, prostate cancer, and endometrial cancer. In breast cancer, for instance, estrogen and/or progesterone can bind to their respective receptors on the surface of cancer cells, leading to the activation of signaling pathways that promote tumor growth. Similarly, in prostate cancer, androgens such as testosterone can bind to androgen receptors on the surface of cancer cells, promoting cell division and tumor growth.

Hormone-dependent neoplasms are often treated with hormonal therapies that aim to reduce or block the production of the relevant hormones or interfere with their ability to bind to their respective receptors. This can help slow down or stop the growth of the tumor and improve outcomes for patients.

Taxoids are a class of naturally occurring compounds that are derived from the bark of the Pacific yew tree (Taxus brevifolia) and other species of the genus Taxus. They are known for their antineoplastic (cancer-fighting) properties and have been used in chemotherapy to treat various types of cancer, including ovarian, breast, and lung cancer.

The most well-known taxoid is paclitaxel (also known by the brand name Taxol), which was first discovered in the 1960s and has since become a widely used cancer drug. Paclitaxel works by stabilizing microtubules, which are important components of the cell's skeleton, and preventing them from disassembling. This disrupts the normal function of the cell's mitotic spindle, leading to cell cycle arrest and ultimately apoptosis (programmed cell death).

Other taxoids that have been developed for clinical use include docetaxel (Taxotere), which is a semi-synthetic analogue of paclitaxel, and cabazitaxel (Jevtana), which is a second-generation taxoid. These drugs have similar mechanisms of action to paclitaxel but may have different pharmacokinetic properties or be effective against cancer cells that have developed resistance to other taxoids.

While taxoids have been successful in treating certain types of cancer, they can also cause significant side effects, including neutropenia (low white blood cell count), anemia (low red blood cell count), and peripheral neuropathy (nerve damage). As with all chemotherapy drugs, the use of taxoids must be carefully balanced against their potential benefits and risks.

Antineoplastic agents, hormonal, are a class of drugs used to treat cancers that are sensitive to hormones. These agents work by interfering with the production or action of hormones in the body. They can be used to slow down or stop the growth of cancer cells and may also help to relieve symptoms caused by the spread of cancer.

Hormonal therapies can work in one of two ways: they can either block the production of hormones or prevent their action on cancer cells. For example, some hormonal therapies work by blocking the action of estrogen or testosterone, which are hormones that can stimulate the growth of certain types of cancer cells.

Examples of hormonal agents used to treat cancer include:

* Aromatase inhibitors (such as letrozole, anastrozole, and exemestane), which block the production of estrogen in postmenopausal women
* Selective estrogen receptor modulators (such as tamoxifen and raloxifene), which block the action of estrogen on cancer cells
* Luteinizing hormone-releasing hormone agonists (such as leuprolide, goserelin, and triptorelin), which block the production of testosterone in men
* Antiandrogens (such as bicalutamide, flutamide, and enzalutamide), which block the action of testosterone on cancer cells

Hormonal therapies are often used in combination with other treatments, such as surgery or radiation therapy. They may be used to shrink tumors before surgery, to kill any remaining cancer cells after surgery, or to help control the spread of cancer that cannot be removed by surgery. Hormonal therapies can also be used to relieve symptoms and improve quality of life in people with advanced cancer.

It's important to note that hormonal therapies are not effective for all types of cancer. They are most commonly used to treat breast, prostate, and endometrial cancers, which are known to be sensitive to hormones. Hormonal therapies may also be used to treat other types of cancer in certain situations.

Like all medications, hormonal therapies can have side effects. These can vary depending on the specific drug and the individual person. Common side effects of hormonal therapies include hot flashes, fatigue, mood changes, and sexual dysfunction. Some hormonal therapies can also cause more serious side effects, such as an increased risk of osteoporosis or blood clots. It's important to discuss the potential risks and benefits of hormonal therapy with a healthcare provider before starting treatment.

Prednisone is a synthetic glucocorticoid, which is a type of corticosteroid hormone. It is primarily used to reduce inflammation in various conditions such as asthma, allergies, arthritis, and autoimmune disorders. Prednisone works by mimicking the effects of natural hormones produced by the adrenal glands, suppressing the immune system's response and reducing the release of substances that cause inflammation.

It is available in oral tablet form and is typically prescribed to be taken at specific times during the day, depending on the condition being treated. Common side effects of prednisone include increased appetite, weight gain, mood changes, insomnia, and easy bruising. Long-term use or high doses can lead to more serious side effects such as osteoporosis, diabetes, cataracts, and increased susceptibility to infections.

Healthcare providers closely monitor patients taking prednisone for extended periods to minimize the risk of adverse effects. It is essential to follow the prescribed dosage regimen and not discontinue the medication abruptly without medical supervision, as this can lead to withdrawal symptoms or a rebound of the underlying condition.

Antineoplastic agents are a class of drugs used to treat malignant neoplasms or cancer. These agents work by inhibiting the growth and proliferation of cancer cells, either by killing them or preventing their division and replication. Antineoplastic agents can be classified based on their mechanism of action, such as alkylating agents, antimetabolites, topoisomerase inhibitors, mitotic inhibitors, and targeted therapy agents.

Alkylating agents work by adding alkyl groups to DNA, which can cause cross-linking of DNA strands and ultimately lead to cell death. Antimetabolites interfere with the metabolic processes necessary for DNA synthesis and replication, while topoisomerase inhibitors prevent the relaxation of supercoiled DNA during replication. Mitotic inhibitors disrupt the normal functioning of the mitotic spindle, which is essential for cell division. Targeted therapy agents are designed to target specific molecular abnormalities in cancer cells, such as mutated oncogenes or dysregulated signaling pathways.

It's important to note that antineoplastic agents can also affect normal cells and tissues, leading to various side effects such as nausea, vomiting, hair loss, and myelosuppression (suppression of bone marrow function). Therefore, the use of these drugs requires careful monitoring and management of their potential adverse effects.

Androgen receptors (ARs) are a type of nuclear receptor protein that are expressed in various tissues throughout the body. They play a critical role in the development and maintenance of male sexual characteristics and reproductive function. ARs are activated by binding to androgens, which are steroid hormones such as testosterone and dihydrotestosterone (DHT). Once activated, ARs function as transcription factors that regulate gene expression, ultimately leading to various cellular responses.

In the context of medical definitions, androgen receptors can be defined as follows:

Androgen receptors are a type of nuclear receptor protein that bind to androgens, such as testosterone and dihydrotestosterone, and mediate their effects on gene expression in various tissues. They play critical roles in the development and maintenance of male sexual characteristics and reproductive function, and are involved in the pathogenesis of several medical conditions, including prostate cancer, benign prostatic hyperplasia, and androgen deficiency syndromes.

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

Androgen receptor antagonists are a class of drugs that block the action of androgens, which are hormones responsible for the development and maintenance of male sexual characteristics. These drugs work by binding to the androgen receptors in cells, preventing the natural androgens such as testosterone and dihydrotestosterone from binding and exerting their effects.

Androgen receptor antagonists are often used in the treatment of prostate cancer because androgens can stimulate the growth of prostate cancer cells. By blocking the action of androgens, these drugs can help to slow or stop the growth of prostate cancer tumors. Some examples of androgen receptor antagonists include flutamide, bicalutamide, and enzalutamide.

It's important to note that androgen receptor antagonists can have side effects, including hot flashes, breast tenderness or enlargement, decreased sex drive, and impotence. Additionally, long-term use of these drugs can lead to muscle loss, bone density loss, and an increased risk of fractures. As with any medication, it's important to discuss the potential benefits and risks with a healthcare provider before starting treatment.

Tetradecanoylphorbol acetate (TPA) is defined as a pharmacological agent that is a derivative of the phorbol ester family. It is a potent tumor promoter and activator of protein kinase C (PKC), a group of enzymes that play a role in various cellular processes such as signal transduction, proliferation, and differentiation. TPA has been widely used in research to study PKC-mediated signaling pathways and its role in cancer development and progression. It is also used in topical treatments for skin conditions such as psoriasis.

Biosynthetic pathways refer to the series of biochemical reactions that occur within cells and living organisms, leading to the production (synthesis) of complex molecules from simpler precursors. These pathways involve a sequence of enzyme-catalyzed reactions, where each reaction builds upon the product of the previous one, ultimately resulting in the formation of a specific biomolecule.

Examples of biosynthetic pathways include:

1. The Krebs cycle (citric acid cycle) - an essential metabolic pathway that generates energy through the oxidation of acetyl-CoA derived from carbohydrates, fats, and proteins.
2. Glycolysis - a process that breaks down glucose into pyruvate to generate ATP and NADH.
3. Gluconeogenesis - the synthesis of glucose from non-carbohydrate precursors such as lactate, pyruvate, glycerol, and certain amino acids.
4. Fatty acid synthesis - a process that produces fatty acids from acetyl-CoA and malonyl-CoA through a series of reduction reactions.
5. Amino acid synthesis - the production of various amino acids from simpler precursors, often involving intermediates in central metabolic pathways like the Krebs cycle or glycolysis.
6. Steroid biosynthesis - the formation of steroids from simple precursors such as cholesterol and its derivatives.
7. Terpenoid biosynthesis - the production of terpenes, terpenoids, and sterols from isoprene units (isopentenyl pyrophosphate).
8. Nucleotide synthesis - the generation of nucleotides, the building blocks of DNA and RNA, through complex biochemical pathways involving various precursors and cofactors.

Understanding biosynthetic pathways is crucial for comprehending cellular metabolism, developing drugs that target specific metabolic processes, and engineering organisms with desired traits in synthetic biology and metabolic engineering applications.

Tissue extracts refer to the substances or compounds that are extracted from various types of biological tissues, such as plants, animals, or microorganisms. These extracts contain bioactive molecules, including proteins, peptides, lipids, carbohydrates, nucleic acids, and other small molecules, which can have therapeutic or diagnostic potential. The process of tissue extraction involves homogenizing the tissue, followed by separation and purification of the desired components using various techniques such as centrifugation, filtration, chromatography, or precipitation.

In medical research and clinical settings, tissue extracts are often used to study the biochemical and molecular properties of cells and tissues, investigate disease mechanisms, develop diagnostic tests, and identify potential drug targets. Examples of tissue extracts include cell lysates, subcellular fractions, organelle preparations, plasma membrane extracts, nuclear extracts, and various types of protein or nucleic acid extracts. It is important to note that the quality and purity of tissue extracts can significantly impact the accuracy and reproducibility of experimental results, and appropriate controls and validation methods should be employed to ensure their proper use.

Phase III clinical trials are a type of medical research study that involves testing the safety and efficacy of a new drug, device, or treatment in a large group of people. These studies typically enroll hundreds to thousands of participants, who are randomly assigned to receive either the experimental treatment or a standard of care comparison group.

The primary goal of Phase III clinical trials is to determine whether the new treatment works better than existing treatments and to assess its safety and side effects in a larger population. The data collected from these studies can help regulatory agencies like the U.S. Food and Drug Administration (FDA) decide whether to approve the new treatment for use in the general population.

Phase III clinical trials are usually conducted at multiple centers, often across different countries, to ensure that the results are generalizable to a wide range of patients. Participants may be followed for several years to assess long-term safety and efficacy outcomes.

Overall, Phase III clinical trials play a critical role in ensuring that new treatments are safe and effective before they become widely available to patients.

In medical terminology, a budget is not explicitly defined. However, in a general sense, it refers to a financial plan that outlines the anticipated costs and expenses for a specific period. In healthcare, budgets can be used by hospitals, clinics, or other medical facilities to plan for and manage their finances.

A healthcare organization's budget may include expenses related to:

* Salaries and benefits for staff
* Equipment and supply costs
* Facility maintenance and improvements
* Research and development expenses
* Insurance and liability coverage
* Marketing and advertising costs

Budgets can help healthcare organizations manage their finances effectively, allocate resources efficiently, and make informed decisions about spending. They may also be used to plan for future growth and expansion.

Drug resistance in neoplasms (also known as cancer drug resistance) refers to the ability of cancer cells to withstand the effects of chemotherapeutic agents or medications designed to kill or inhibit the growth of cancer cells. This can occur due to various mechanisms, including changes in the cancer cell's genetic makeup, alterations in drug targets, increased activity of drug efflux pumps, and activation of survival pathways.

Drug resistance can be intrinsic (present at the beginning of treatment) or acquired (developed during the course of treatment). It is a significant challenge in cancer therapy as it often leads to reduced treatment effectiveness, disease progression, and poor patient outcomes. Strategies to overcome drug resistance include the use of combination therapies, development of new drugs that target different mechanisms, and personalized medicine approaches that consider individual patient and tumor characteristics.

Acetate kinase is an enzyme that catalyzes the reversible phosphorylation of acetate to form acetyl phosphate and ADP (adenosine diphosphate) from ATP (adenosine triphosphate). The reaction is as follows:

Acetate + ATP -> Acetyl phosphate + ADP

This enzyme plays a role in the metabolism of certain bacteria and archaea, where it helps to generate energy in the form of ATP. It is not typically found in humans or other mammals.

Dihydrotestosterone (DHT) is a sex hormone and androgen that plays a critical role in the development and maintenance of male characteristics, such as facial hair, deep voice, and muscle mass. It is synthesized from testosterone through the action of the enzyme 5-alpha reductase. DHT is essential for the normal development of the male genitalia during fetal development and for the maturation of the sexual organs at puberty.

In addition to its role in sexual development, DHT also contributes to the growth of hair follicles, the health of the prostate gland, and the maintenance of bone density. However, an excess of DHT has been linked to certain medical conditions, such as benign prostatic hyperplasia (BPH) and androgenetic alopecia (male pattern baldness).

DHT exerts its effects by binding to androgen receptors in various tissues throughout the body. Once bound, DHT triggers a series of cellular responses that regulate gene expression and influence the growth and differentiation of cells. In some cases, these responses can lead to unwanted side effects, such as hair loss or prostate enlargement.

Medications that block the action of 5-alpha reductase, such as finasteride and dutasteride, are sometimes used to treat conditions associated with excess DHT production. These drugs work by reducing the amount of DHT available to bind to androgen receptors, thereby alleviating symptoms and slowing disease progression.

In summary, dihydrotestosterone is a potent sex hormone that plays a critical role in male sexual development and function. While it is essential for normal growth and development, an excess of DHT has been linked to certain medical conditions, such as BPH and androgenetic alopecia. Medications that block the action of 5-alpha reductase are sometimes used to treat these conditions by reducing the amount of DHT available to bind to androgen receptors.

An encyclopedia is a comprehensive reference work containing articles on various topics, usually arranged in alphabetical order. In the context of medicine, a medical encyclopedia is a collection of articles that provide information about a wide range of medical topics, including diseases and conditions, treatments, tests, procedures, and anatomy and physiology. Medical encyclopedias may be published in print or electronic formats and are often used as a starting point for researching medical topics. They can provide reliable and accurate information on medical subjects, making them useful resources for healthcare professionals, students, and patients alike. Some well-known examples of medical encyclopedias include the Merck Manual and the Stedman's Medical Dictionary.

Ketoconazole is an antifungal medication that is primarily used to treat various fungal infections, including those caused by dermatophytes, Candida, and pityrosporum. It works by inhibiting the synthesis of ergosterol, a crucial component of fungal cell membranes, which leads to increased permeability and ultimately results in fungal cell death.

Ketoconazole is available as an oral tablet for systemic use and as a topical cream or shampoo for localized applications. The oral formulation is used to treat severe or invasive fungal infections, while the topical preparations are primarily indicated for skin and scalp infections, such as athlete's foot, ringworm, jock itch, candidiasis, and seborrheic dermatitis.

Common side effects of oral ketoconazole include nausea, vomiting, headache, and altered liver function tests. Rare but serious adverse reactions may include hepatotoxicity, adrenal insufficiency, and interactions with other medications that can affect the metabolism and elimination of drugs. Topical ketoconazole is generally well-tolerated, with local irritation being the most common side effect.

It's important to note that due to its potential for serious liver toxicity and drug-drug interactions, oral ketoconazole has been largely replaced by other antifungal agents, such as fluconazole and itraconazole, which have more favorable safety profiles. Topical ketoconazole remains a valuable option for treating localized fungal infections due to its effectiveness and lower risk of systemic side effects.

Supplied as abiraterone acetate it is converted in the body to abiraterone. Abiraterone acetate works by suppressing the ... Abiraterone acetate is the C3β acetate ester of abiraterone. In the early 1990s, Mike Jarman, Elaine Barrie, and Gerry Potter ... After a median follow-up period of 22.2 months, overall survival was better with abiraterone acetate. Abiraterone acetate may ... Abiraterone acetate, also known as 17-(3-pyridinyl)androsta-5,16-dien-3β-ol acetate, is a synthetic androstane steroid and a ...
"Abiraterone Acetate". Coleman et al. 2020, "Prevalence of bone metastases". Coleman et al. 2020, "Prevalence of SREs". Coleman ... as well as the testosterone production inhibitor abiraterone acetate (which disrupts the balance of other hormones, and so is ... These are typically treated with appetite-increasing drugs - megestrol acetate or corticosteroids - antiemetics, or treatments ...
SOC plus abiraterone acetate and prednisolone. SOC plus RT. SOC plus abiraterone and enzalutamide and prednisolone. SOC plus ... this is called overall survival adding abiraterone to hormone therapy improves overall survival and delays the time until the ...
... and androgen synthesis inhibitors such as ketoconazole and abiraterone acetate. v t e Hormone levels with GnRH agonists and ... These include antigonadotropins such as progestogens like cyproterone acetate and chlormadinone acetate and estrogens like ... Sugiono M, Winkler MH, Okeke AA, Benney M, Gillatt DA (2005). "Bicalutamide vs cyproterone acetate in preventing flare with ... "Goserelin acetate with or without antiandrogen or estrogen in the treatment of patients with advanced prostate cancer: a ...
It is formed as follows: abiraterone acetate to abiraterone by esterases; abiraterone to Δ4-abiraterone by 3β-hydroxysteroid ... 3-Keto-5α-abiraterone, also known as 17-(3-pyridyl)-5α-androst-16-en-3-one, is an active metabolite of abiraterone acetate that ... 3-Keto-5α-abiraterone may counteract the clinical effectiveness of abiraterone acetate, and so inhibition of its formation ... and Δ4-abiraterone to 3-keto-5α-abiraterone by 5α-reductase. ... is being investigated as an adjunct to abiraterone acetate in ...
"Abiraterone acetate to lower androgens in women with classic 21-hydroxylase deficiency". J Clin Endocrinol Metab. 99 (8): 2763- ...
"Abiraterone acetate to lower androgens in women with classic 21-hydroxylase deficiency". J Clin Endocrinol Metab. 99 (8): 2763- ...
... may be effective in a subset of prostate cancer patients with acquired resistance to abiraterone acetate. ... which the NSAA enzalutamide and the androgen synthesis inhibitor abiraterone acetate are used to treat. Apalutamide is provided ... "FDA Approves Apalutamide for Nonmetastatic Prostate Cancer". Schweizer MT, Antonarakis ES (August 2012). "Abiraterone and other ... Pinto Á (February 2014). "Beyond abiraterone: new hormonal therapies for metastatic castration-resistant prostate cancer". ...
... and levoketoconazole include the nonsteroidal compound aminoglutethimide and the steroidal compound abiraterone acetate.[ ...
Abiraterone Acetate and Enzalutamide". Clin Pharmacokinet. 55 (11): 1369-1380. doi:10.1007/s40262-016-0403-6. PMC 5069300. PMID ...
Abiraterone Acetate and Enzalutamide". Clin Pharmacokinet. 55 (11): 1369-1380. doi:10.1007/s40262-016-0403-6. PMC 5069300. PMID ... "Hormonal Therapeutics Enzalutamide and Abiraterone Acetate in the Treatment of Metastatic Castration-Resistant Prostate Cancer ... "AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer". New England Journal of Medicine. 371 (11): 1028-38. ... though reportedly not as effective as cyproterone acetate in reducing testosterone levels [12]. Both flutamide and bicalutamide ...
Johnson in 2009 based solely on abiraterone acetate. This drug was not yet in phase III clinical trials for its application in ...
The CYP17A1 inhibitors that have been marketed, like abiraterone acetate, are used mainly in the treatment of prostate cancer. ... Examples of CYP17A1 inhibitors include the older drug ketoconazole and the newer drugs abiraterone acetate, orteronel, ... "CYP17A1 inhibitor abiraterone, an anti-prostate cancer drug, also inhibits the 21-hydroxylase activity of CYP21A2". The Journal ...
Abiraterone acetate inhibits an enzyme known as CYP17, which is used in the body to produce testosterone. A review from 2020 ... Abiraterone acetate was FDA approved in April 2011 for treatment of castration-resistant prostate cancer for patients who have ... October 2008). "Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration- ... Cochrane Urology Group) (December 2020). "Abiraterone acetate in combination with androgen deprivation therapy compared to ...
Abiraterone acetate binds in the active site of the enzyme and coordinates the heme iron through its pyridine nitrogen, ... The drug abiraterone acetate, which is used to treat castration-resistant prostate cancer, blocks the biosynthesis of androgens ... This is in contrast to the abiraterone acetate, that permanently (rather than competitively) disables CYP17A1, once it binds to ... abiraterone, which contains a steroidal scaffold that is similar to the endogenous CYP17A1 substrates. Abiraterone is ...
Steroidal antiandrogens include compounds like cyproterone acetate, spironolactone, estradiol, abiraterone acetate, and ... These drugs include the steroidal antiandrogens cyproterone acetate, megestrol acetate, chlormadinone acetate, spironolactone, ... Ketoconazole and abiraterone acetate are inhibitors of the enzyme CYP17A1, also known as 17α-hydroxylase/17,20-lyase, which is ... medroxyprogesterone acetate, megestrol acetate, osaterone acetate (veterinary), and oxendolone, and estrogens like estradiol, ...
In April 2011, the United States Food and Drug Administration approved abiraterone acetate (Zytiga), Cougar's lead product, for ...
... another active metabolite of abiraterone acetate). D4A is formed from abiraterone by 3β-hydroxysteroid dehydrogenase/Δ5-4 ... is a steroidogenesis inhibitor and active metabolite of abiraterone acetate, a drug which is used in the treatment of prostate ... and the addition of this medication may improve the effectiveness of abiraterone acetate in the treatment of prostate cancer. ... and is partially responsible for the activity of abiraterone acetate. D4A is specifically an inhibitor of CYP17A1 (17α- ...
... abiraterone acetate, and other aromatase inhibitors. It remains marketed only in a few countries. AG is used as an ... abiraterone acetate, and other aromatase inhibitors. Aminoglutethimide is the generic name of the drug and its INNTooltip ... Dosages of theophylline, digitoxin, and medroxyprogesterone acetate may need to be increased. AG is a potent and non-selective ...
Abiraterone acetate Ketoconazole Seviteronel Aminoglutethimide Alfatradiol Dutasteride Epristeride Finasteride Saw palmetto ... acetate Cyproterone acetate Megestrol acetate Osaterone acetate 19-Norprogesterone derivatives Nomegestrol acetate 19- ... chlormadinone acetate, cyproterone acetate, gestonorone caproate, medroxyprogesterone acetate, megestrol acetate) List of ...
... abiraterone acetate, and enzalutamide. In addition, estrogens may offer significant benefits over other means of androgen ... cytestrol acetate, estradiol mustard, ICI-85966, and phenestrol. Due to its hydrophilic phosphate ester moiety, EMP is a ...
A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate (CB7630) Plus Prednisone in Patients with ... A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate (CB7630) Plus Prednisone in Asymptomatic ... "Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: Final overall survival analysis of the ...
... and through which he in-licensed abiraterone acetate from BTG plc. Cougar further developed abiraterone before the company was ...
The medicine must also not be used with abiraterone acetate, prednisone or prednisolone and its use is not recommended in ...
Similarly to abiraterone acetate, seviteronel has also been found to act to some extent as an antagonist of the androgen ... Seviteronel is 58-fold more selective for inhibition of 17,20-lyase than abiraterone (the active metabolite of abiraterone ... In addition, in in vitro models, seviteronel appears to possess greater efficacy as an antiandrogen relative to abiraterone. ... results in less interference with corticosteroid production relative to the approved CYP17A1 inhibitor abiraterone acetate ( ...
... has been intimately involved in developing studies that have led to the registration of abiraterone acetate and ... Abiraterone was approved in the USA the day after the FDA inspection at Dr. Sternberg's department in Italy. She is a Principal ... Sternberg is a member of the steering committee of a study of the combination of abiraterone and an AKT inhibitor, ipatasertib ...
New antiandrogens that target testosterone synthesis (abiraterone acetate and seviteronel) or AR nuclear translocation ( ... The main antiandrogens are cyproterone acetate, flutamide, nilutamide, bicalutamide, and enzalutamide which are all ...
Steroidal androgen synthesis inhibitors like the CYP17A1 inhibitor abiraterone acetate (Zytiga) or the 5α-reductase inhibitors ... Inocoterone acetate (RU-38882, RU-882): A steroid-like NSAA. It was under development as a topical medication for the treatment ... Nomegestrol acetate (Lutenyl): Progestin with AR antagonist activity. Used in the treatment of gynecological disorders and in ... Megestrol acetate (Megace): A combined AR partial antagonist and progestogen/antigonadotropin. Also has weak androgenic and ...
17α-Hydroxylase/17,20-lyase (CYP17A1) inhibitors such as abiraterone acetate, etomidate, galeterone, ketoconazole, and ...
... with progression after enzalutamide or abiraterone". Journal of Clinical Oncology. ISSN 0732-183X. Archived from the original ... Ralaniten acetate (developmental code name EPI-506) is a first-in-class antiandrogen that targets the N-terminal domain (NTD) ... Ralaniten acetate - AdisInsight v t e v t e (Articles with short description, Short description matches Wikidata, Articles ... EPI-7386 N-Terminal domain antiandrogen "Ralaniten acetate - ESSA Pharma". AdisInsight. Springer Nature Switzerland AG. ...
Supplied as abiraterone acetate it is converted in the body to abiraterone. Abiraterone acetate works by suppressing the ... Abiraterone acetate is the C3β acetate ester of abiraterone. In the early 1990s, Mike Jarman, Elaine Barrie, and Gerry Potter ... After a median follow-up period of 22.2 months, overall survival was better with abiraterone acetate. Abiraterone acetate may ... Abiraterone acetate, also known as 17-(3-pyridinyl)androsta-5,16-dien-3β-ol acetate, is a synthetic androstane steroid and a ...
Abiraterone acetate (A‐bir‐a‐ter‐one as‐e‐tate) tablets What is abiraterone acetate tablet? Abiraterone acetate tablet is a ... Abiraterone acetate, the active ingredient of abiraterone acetate tablets USP is the acetyl ester of abiraterone. Abiraterone ... In vivo, abiraterone acetate is converted to abiraterone. In clinical studies, abiraterone acetate plasma concentrations were ... Following oral administration of 14C-abiraterone acetate as capsules, abiraterone acetate is hydrolyzed to abiraterone (active ...
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
Interim results from a study led by the Duke Cancer Institute suggest that a drug…. Read More ...
The FDA has approved niraparib plus abiraterone acetate, given with prednisone, for the treatment of adult patients with ... U.S. FDA approves AKEEGA (niraparib and abiraterone acetate), the first-and-only dual action tablet for the treatment of ... FDA Approves Niraparib Plus Abiraterone Acetate for BRCA+ mCRPC August 11, 2023. Caroline Seymour ... The approval is based on findings from the phase 3 MAGNITUDE trial (NCT03748641), in which niraparib and abiraterone acetate ...
Adding abiraterone acetate to androgen deprivation therapy for the treatment of metastatic hormone-sensitive prostate cancer. ... Abiraterone acetate in addition to ADT probably results in little to no difference in quality of life compared to ADT alone, ... The addition of abiraterone acetate to ADT reduces the probability of death from any cause compared to ADT alone (hazard ratio ... The studies compared abiraterone acetate and hormone therapy to hormone therapy alone. In one of the studies, most of the ...
This study is being done to see how safe and effective abemaciclib is when given together with abiraterone acetate plus ... with abiraterone acetate plus prednisone in participants with metastatic castration resistant. prostate cancer. Prednisolone ... A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate plus Prednisone with or without ...
... progression-free survival for niraparib and abiraterone acetate plus prednisone compared to placebo and abiraterone acetate ... 1 to receive niraparib at 200 mg and abiraterone acetate at 1,000 mg plus prednisone at 10 mg daily, or placebo and abiraterone ... The recommended dose of the agent is 200 mg of niraparib and 1,000 mg of abiraterone acetate taken orally once daily in ... Patients receiving niraparib and abiraterone acetate plus prednisone should also receive a GnRH analog concurrently or should ...
Study on Stress Degradation Behaviour of Abiraterone Acetate in Film Coated Tablets and Identification of Major Stress ... Gong A, Zhu X. β-cyclodextrin sensitized spectrofluorimetry for the determination of abiraterone acetate and abiraterone. J ... Abiraterone acetate is an androgen biosynthesis inhibitor used in the treatment of prostate cancer. This study focuses on a ... Abiraterone Acetate (ABT), the first compound through the inhibition of adrenal gland production of testosterone, increases the ...
... to enhance the therapeutical effect of abiraterone acetate on prostate cancer patients who are resistant to abiraterone acetate ... miR-143 mediates abiraterone acetate resistance by regulating the JNK/Bcl-2 signaling pathway in prostate cancer Yigeng Feng#, ... miR-143 mediates abiraterone acetate resistance by regulating the JNK/Bcl-2 signaling pathway in prostate cancer. J Cancer. 13( ... Feng Y, Cao H, Zhao W, Chen L, Wang D, Gao R. miR-143 mediates abiraterone acetate resistance by regulating the JNK/Bcl-2 ...
Shipping Worldwide, Know Abiraterone Acetate Tablets Price, uses side effects, warnings, and precautions at LetsMeds Pharmacy ... Find Abiraterone Acetate Tablets branded and generic alternatives cost online. ... What is Abiraterone Acetate Tablets Philippines?. Abiraterone Acetate 250mg Tablets is a medication used to treat advanced ... Can Abiraterone Acetate cure prostate cancer?. . Abiraterone 250mg Tablets USA is not a curative treatment for prostate cancer ...
... abiraterone acetate) and find out if it is the right treatment option for you. See Full Safety and Prescribing Information. ... ZYTIGA® (abiraterone acetate) is a prescription medicine that is used along with prednisone. ZYTIGA® is used to treat men with ...
Abiraterone Acetate. Home / Products / Drug Substance Reference Standards / Abiraterone Acetate. Products. , Drug Substance ... Synonyms -(3ß)17-(3-pyridinyl)androsta-5,16-dien-3-yl acetate ... Abiraterone Acetate. Pricing & Availability. $150.00. Unit Size ...
Zytix contains the active ingredient Abiraterone Acetate, a steroidal antiandroge used with prednisone to treat metastatic ... Zytix (Abiraterone Acetate) Image. Product. Zytix (Abiraterone Acetate) - 250mg (6 Tablets) USD$126.00 , * Out of Stock,please ... What is Zytix (Abiraterone Acetate) used for?. Zytix contains the active ingredient Abiraterone Acetate, a steroidal ... How should I use Zytix (Abiraterone Acetate)?. Zytix is sold as a box of 6 tablets. Eac table contains 250mg of Abiraterone ...
Abiraterone Acetate Second-Line Treatment of Metastatic Castrate-Resistant Prostate Cancer (mCRPC) is.... Editorial Team - ... Data for Abiraterone Acetate Plus Prednisone in Metastatic Castration-Resistant Prostate Cancer.... Editorial Team - December ...
Abiraterone Acetate) is used along with prednisone in the treatment of certain cases of prostate cancer. It is indicated in ... Zytix (Abiraterone Acetate) is used along with prednisone in the treatment of certain cases of prostate cancer. It is indicated ... Zytix (Abiraterone Acetate) is used along with prednisone in the treatment of certain cases of prostate cancer. It is indicated ... Zytix comes in a pack of 6 tablets, each containing 250mg of the active ingredient Abiraterone Acetate. ...
Abiraterone Acetate and Jaundice. This page shows results related to Abiraterone Acetate and Jaundice from the FDA Adverse ... To learn more about all adverse events for Abiraterone Acetate, view the complete Abiraterone Acetate adverse event report. ...
Be the first to review "Abirapro 250mg Tablet (Abiraterone Acetate 250mg)" Cancel reply. Your rating. Rate…. Perfect. Good. ... ABIRAPRO 250MG contains abiraterone which belongs to the group of medicines called antineoplastic agents. It is used to treat ... Abiraterone inhibits androgen production in your body and reduces the growth of prostate cancer. This medicine must not be ...
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the ... Find out how to dose and monitor the use of ZYTIGA® (abiraterone acetate) for your patients. ... Exploratory analysis of the visceral disease subgroup in a Phase 3 study of abiraterone acetate in metastatic castration- ... Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med. 2011;364(21):1995-2005. ...
Abiraterone acetate is converted in vivo to abiraterone, an androgen biosynthesis inhibitor, that inhibits 17 α-hydroxylase/C17 ... AbiraPro is a branded , affordable generic brand of Abiraterone. There are other generic option available for Abiraterone from ...
Generic Abiraterone Acetate of Zytix, Abiret, Abirapro, Zyterone, Zytiga Buying Cost Online. [email protected] ... Abiraterone Acetate #Generic Abiraterone Acetate #Generic Abiraterone Acetate Cost / Price #Generic Abiraterone Acetate Cost / ... Generic Zytiga Generic Abiraterone Acetate Price Buy Online Buy Generic Zytiga prescription medicine. Generic Abiraterone ...
... Int J Pharm Sci Drug Anal 2023;3(1):98-103. ... Process validation of abiraterone acetate tablets USP 250 MG. Author(s): Prakash Choudhary, Ramakant Sharma, Jeevan Patel, ... To perform Concurrent process validation for Abiraterone Acetate Tablets USP 250 mg. The protocol describes the different ... acceptance criteria the process of manufacturing of abiraterone acetate tablets up 250 mg as per manufacturing document, master ...
Abiraterone acetate tablets is specially for prostate cancer medications. Dial 8130290915 for Abirapro. ... Buy Abirapro 250 mg or Abiraterone acetate 250 mg at best price. ... Abiraterone Dosage:. Abiraterone Acetate 250mg should be taken ... What is Abiraterone Acetate and what it is used for:. Abiraterone acetate is a CYP17 inhibitor used to treat metastatic ... One should take Abiraterone 250 mg on an empty stomach as exposure to food increases the abiraterone acetate concentration. ...
So many people around the world prefer Indian generic Abiraterone. Acetate Abirapro 250 mg or other Abiraterone acetate generic ... Abiraterone acetate).. As a result, Abirapro (Abiraterone Acetate 250mg) may cause hypertension [high blood pressure], ... What is abiraterone acetate used for?. Abiraterone is used in blend with prednisone to treat a particular type of prostate ... How does abiraterone acetate work?. Abiraterone works by Stopping the body creating a hormone called testosterone. It does this ...
it contains Abiraterone Acetate which is Liver Cancer Treatment. We deal in South Africa, NIgeria, Uganda, Usa, Australia. ... What is Dose of Xbira 250mg Tablet (Abiraterone Acetate)?. *XBIRA (abiraterone acetate) is a pill that needs to be swallowed. ... What is Use of Xbira 250mg Tablet (Abiraterone Acetate)?. Xbira Abiraterone Acetate Tablets 250mg is a treatment for prostate ... What is Xbira 250mg Tablet (Abiraterone Acetate)?. Antiandrogens are a group of medications that include Abiraterone Acetate ...
The safety profile of niraparib and abiraterone acetate plus prednisone was consistent with the known safety profile of each ... The US Food and Drug Administration (FDA) has approved niraparib and abiraterone acetate (Akeega, Janssen Pharmaceuticals) to ... Cite this: FDA OKs Combo Niraparib, Abiraterone Acetate for Prostate Cancer - Medscape - Aug 11, 2023. ... tablet is the first-and-only orally administered treatment combining the PARP inhibitor niraparib with abiraterone acetate. ...
Abiraterone acetate (Synonyms: CB7630) 纯度: 99.92% Abiraterone acetate (CB7630) 是一种口服、有效、选择性和不可逆的 CYP17A1 抑制剂,具有抗雄激素活性。 ... Abiraterone (Abi) acetate is an ester prodrug of the anticancer agent Abiraterone, which shows IC50 values of 15 nM and 2.5 nM ... 此条目由上海金畔生物科技有限公司发表在
Cost of zytiga 250 mg generic (abiraterone 250 mg tablets) Canada USA. ... Abiraterone Acetate Tablets Generic Zytiga Cost Canada USA to Buy Online. ... cost of abiraterone 250 mg , zytiga generic cost. Zytiga Generic (Abiraterone Acetate Tablets) works by lowering the ... Where you can buy an abiraterone acetate cost canada, zytiga price usa? Abiraterone Generic Cost: This prescription is ...
  • Abiraterone Acetate 250mg Tablets is a medication used to treat advanced prostate cancer. (letsmeds.com)
  • Abiraterone 250mg Tablets USA is not a curative treatment for prostate cancer, but it can be effective in slowing the progression of the disease and improving the patient's quality of life. (letsmeds.com)
  • While Generic Abiraterone 250mg Tablets Malaysia cannot cure prostate cancer, it can be an effective treatment option for many patients and can help to extend their life and improve their quality of life. (letsmeds.com)
  • In the United States, the average wholesale price (AWP) for a 30-day supply of Abiraterone 250mg Tablet is around $10,000, but the actual out-of-pocket cost for the patient may be lower or higher depending on their insurance coverage and any available discounts or financial assistance programs. (letsmeds.com)
  • Eac table contains 250mg of Abiraterone Acetate. (4nrx.md)
  • Zytix comes in a pack of 6 tablets, each containing 250mg of the active ingredient Abiraterone Acetate. (unitedpharmacies.com)
  • ABIRAPRO 250MG contains abiraterone which belongs to the group of medicines called antineoplastic agents. (genericbucket.com)
  • What is Xbira 250mg Tablet (Abiraterone Acetate)? (kegg-biotech.com)
  • Xbira Abiraterone Acetate Tablets 250mg is a treatment for prostate cancer that has progressed to other regions of the body in adult men. (kegg-biotech.com)
  • What is Precaution of using Xbira 250mg Tablet (Abiraterone Acetate)? (kegg-biotech.com)
  • Abiraterone Acetate 250mg should be taken orally at about the same time each day, without food. (theindianpharma.com)
  • Abirapro 250mg price Abiraterone works by lowering androgen production in the body. (yourmedikart.store)
  • Abiraterone acetate, sold under the brand name Zytiga among others, is a medication used to treat prostate cancer. (wikipedia.org)
  • The FDA has approved the first-and-only dual action tablet (Akeega) combining niraparib (Zejula) and abiraterone acetate (Zytiga), given with prednisone, for the treatment of adult patients with deleterious or suspected deleterious BRCA -positive, metastatic castration-resistant prostate cancer (mCRPC), as detected by an FDA-approved test. (onclive.com)
  • Zytiga Generic (Abiraterone Acetate Tablets) works by lowering the development of androgen in the body. (chawlamedicos.com)
  • Cost of Zytiga 250 mg (Abiraterone Acetate 250 mg Tablets) is used along with steroid drugs (prednisone or methylprednisolone) to fight tumours of the prostate that has spread to other regions of the brain. (chawlamedicos.com)
  • How should I take zytiga (abiraterone)? (chawlamedicos.com)
  • Assessment report for Zytiga (abiraterone) 12 October 2017, EMA/816845/2017. (janusinfo.se)
  • Abiraterone acetate is used in combination with prednisone, a corticosteroid, as a treatment for mCRPC (previously called hormone-resistant or hormone-refractory prostate cancer). (wikipedia.org)
  • Abiraterone acetate tablets 1,000 mg orally once daily with prednisone 5 mg orally twice daily. (nih.gov)
  • Increased fractures and mortality in combination with radium Ra 223 dichloride: Use of abiraterone acetate plus prednisone/prednisolone in combination with radium Ra 223 dichloride is not recommended. (nih.gov)
  • The FDA has approved niraparib plus abiraterone acetate, given with prednisone, for the treatment of adult patients with deleterious or suspected deleterious BRCA-positive, metastatic castration-resistant prostate cancer, as detected by an FDA-approved test. (onclive.com)
  • The phase 3, randomized, double-blind, placebo-controlled multicenter MAGNITUDE trial evaluated the combination of niraparib and abiraterone plus prednisone in patients with treatment-naive mCRPC with or without certain HRR gene alterations. (onclive.com)
  • Patients were randomly assigned to receive niraparib or placebo plus abiraterone and prednisone. (onclive.com)
  • 95% CI, 0.40-1.12) in BRCA -positive patients who received niraparib plus abiraterone and prednisone vs the placebo-based combination. (onclive.com)
  • The search identified two randomized controlled trials (RCT), with 2201 men, who were assigned to receive either abiraterone acetate 1000 mg once daily and low dose prednisone (5mg) in addition to ADT, or ADT alone. (cochrane.org)
  • This study is being done to see how safe and effective abemaciclib is when given together with abiraterone acetate plus prednisone in participants with metastatic castration resistant prostate cancer. (dana-farber.org)
  • On August 11, the U.S. Food and Drug Administration (FDA) approved the fixed-dose combination of niraparib and abiraterone acetate (Akeega), with prednisone, for adult patients with deleterious or suspected deleterious BRCA -mutated metastatic castration-resistant prostate cancer, as determined by an FDA-approved test. (ascopost.com)
  • Patients were randomly assigned 1:1 to receive niraparib at 200 mg and abiraterone acetate at 1,000 mg plus prednisone at 10 mg daily, or placebo and abiraterone acetate plus prednisone daily. (ascopost.com)
  • Patients with metastatic castration-resistant prostate cancer were eligible if they had not received prior systemic therapy in the metastatic castration-resistant prostate cancer setting except for a short duration of prior abiraterone acetate plus prednisone (up to 4 months) and ongoing androgen-deprivation therapy. (ascopost.com)
  • Random assignment was stratified by prior receipt of docetaxel, prior receipt of androgen receptor-targeted therapy, prior receipt of abiraterone acetate plus prednisone, and BRCA status. (ascopost.com)
  • A statistically significant improvement in radiographic progression-free survival for niraparib and abiraterone acetate plus prednisone compared to placebo and abiraterone acetate plus prednisone was observed in patients with a BRCA mutation, with a median of 16.6 months vs 10.9 months (hazard ratio [HR] = 0.53, 95% confidence interval [CI] = 0.36-0.79, P = .0014). (ascopost.com)
  • Among all patients with metastatic castration-resistant prostate cancer treated with niraparib and abiraterone acetate plus prednisone in cohort 1 of MAGNITUDE (n = 423), 27% required a blood transfusion, including 11% who required multiple transfusions. (ascopost.com)
  • The recommended dose of the agent is 200 mg of niraparib and 1,000 mg of abiraterone acetate taken orally once daily in combination with 10 mg of prednisone daily until disease progression or unacceptable toxicity. (ascopost.com)
  • Patients receiving niraparib and abiraterone acetate plus prednisone should also receive a GnRH analog concurrently or should have had bilateral orchiectomy. (ascopost.com)
  • Zytix contains the active ingredient Abiraterone Acetate, a steroidal antiandroge used with prednisone to treat metastatic castration-resistant prostate cancer (hormone-resistant or hormone-refractory prostate cancer). (4nrx.md)
  • Data for Abiraterone Acetate Plus Prednisone in Metastatic Castration-Resistant Prostate Cancer. (oncozine.com)
  • Zytix (Abiraterone Acetate) is used along with prednisone in the treatment of certain cases of prostate cancer. (unitedpharmacies.com)
  • Abiraterone Acetate pill is frequently used in conjunction with another drug called prednisone or prednisolone to lessen the risk of high blood pressure, fluid retention, or low levels of a chemical in the blood (potassium). (kegg-biotech.com)
  • Abiraterone acetate is a CYP17 inhibitor used to treat metastatic castration-resistant prostate cancer when combined with prednisone. (theindianpharma.com)
  • Abiraterone medication is used along with prednisone to treat men with prostate cancer. (yourmedikart.store)
  • Abiraterone acetate is usually prescribed with another medicine called prednisone or prednisolone. (yourmedikart.store)
  • Abiraterone is used in blend with prednisone to treat a particular type of prostate cancer. (yourmedikart.store)
  • The safety profile of niraparib and abiraterone acetate plus prednisone was consistent with the known safety profile of each FDA-approved monotherapy. (medscape.com)
  • The purpose of the study is to determine if the combination of niraparib with Abiraterone Acetate (AA) plus prednisone compared with AA plus prednisone in participants with deleterious germline or somatic Homologous Recombination Repair (HRR) gene-mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC) provides superior efficacy in improving radiographic progression-free survival (rPFS). (uci.edu)
  • Abiraterone acetate plus prednisone (AA-P) is an established standard of care for the treatment of participants with mCSPC and is included in widely accepted clinical treatment guidelines. (uci.edu)
  • Up to a maximum of 45 days of abiraterone acetate + prednisone (AA-P) prior to randomization. (who.int)
  • If patients progressed, they could receive secondary treatment with abiraterone acetate and prednisone. (medscape.com)
  • Plasma cell-free DNA-based predictors of response to abiraterone acetate/prednisone and prognostic factors in metastatic castration-resistant prostate cancer. (cdc.gov)
  • With the nonsteroidal androgen synthesis inhibitor ketoconazole as a model, they developed abiraterone acetate, filing a patent in 1993 and publishing the first paper describing it the following year. (wikipedia.org)
  • Abiraterone acetate is an androgen biosynthesis inhibitor used in the treatment of prostate cancer. (ijpsonline.com)
  • Abiraterone acetate is converted in vivo to abiraterone, an androgen biosynthesis inhibitor, that inhibits 17 α-hydroxylase/C17,20-lyase (CYP17). (indiangenericmedicines.com)
  • Abiraterone acetate (CB7630) is an oral, potent, selective, and irreversible inhibitor of CYP17A1 with antiandrogen activity. (fluoroprobe.com)
  • The once-daily dual-action tablet is the first-and-only orally administered treatment combining the PARP inhibitor niraparib with abiraterone acetate. (medscape.com)
  • abiraterone and leuprolide) with an AKT inhibitor (capivasertib) prior to radical prostatectomy among high-risk localized prostate cancers with PTEN loss. (survivornet.com)
  • U.S. FDA approves AKEEGA (niraparib and abiraterone acetate), the first-and-only dual action tablet for the treatment of patients with BRCA-positive metastatic castration-resistant prostate cancer. (onclive.com)
  • Abiraterone (Abi) acetate prolongs survival in castration-resistant prostate cancer (CRPC). (fluoroprobe.com)
  • The US Food and Drug Administration (FDA) has approved niraparib and abiraterone acetate (Akeega, Janssen Pharmaceuticals) to treat BRCA -positive, metastatic castration-resistant prostate cancer in adult patients with deleterious or suspected deleterious disease, as determined by an FDA-approved test. (medscape.com)
  • Re: Niraparib and Abiraterone Acetate for Metastatic Castration-resistant Prostate Cancer. (bvsalud.org)
  • Cite this: FDA OKs Combo Niraparib, Abiraterone Acetate for Prostate Cancer - Medscape - Aug 11, 2023. (medscape.com)
  • Abiraterone acetate Tablet Online is usually given in combination with corticosteroid medication to reduce the risk of side effects. (letsmeds.com)
  • Indian Abiraterone Acetate Tablet is often used in combination with other treatments, such as chemotherapy or radiation therapy, depending on the stage and severity of the cancer. (letsmeds.com)
  • The dosage of an Abiraterone Acetate tablet depends upon response to treatment, medical condition, and lab results. (theindianpharma.com)
  • Prior use of enzalutamide or abiraterone acetate 3. (druglib.com)
  • Abiraterone acetate works by suppressing the production of androgens - specifically it inhibits CYP17A1 - and thereby decreases the production of testosterone. (wikipedia.org)
  • Abiraterone inhibits androgen production in your body and reduces the growth of prostate cancer. (genericbucket.com)
  • Abiraterone inhibits human 17,20-lyase and 17α-hydroxylase with IC 50 of 27 and 30 nM respectively [1] . (fluoroprobe.com)
  • Abiraterone inhibits recombinant human 3βHSD1 and 3βHSD2 activity with competitive K i values of 2.1 and 8.8 μM. (fluoroprobe.com)
  • Abiraterone acetate inhibits the CYP17 pathway, which is involved in the formation of androgens. (druglib.com)
  • The aim of this review was to find out what the effect of adding abiraterone was, in men with prostate cancer, who were receiving and still responding to hormone therapy. (cochrane.org)
  • The active pharmaceutical ingredient in the medicine Abirapro is Abiraterone acetate with inactive ingredients are lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, povidone, sodium lauryl sulfate, magnesium stearate, and colloidal silicon dioxide. (theindianpharma.com)
  • What is Zytix (Abiraterone Acetate) used for? (4nrx.md)
  • How should I use Zytix (Abiraterone Acetate)? (4nrx.md)
  • What are the side effects of Zytix (Abiraterone Acetate)? (4nrx.md)
  • You must not take Abiraterone is you are pregnant or may become pregnant. (unitedpharmacies.com)
  • One should take Abiraterone 250 mg on an empty stomach as exposure to food increases the abiraterone acetate concentration. (theindianpharma.com)
  • You can take Abiraterone with or without food. (chawlamedicos.com)
  • Take Abiraterone on an empty stomach at least 1 hour before or 2 hours after meals. (chawlamedicos.com)
  • Willing to take abiraterone acetate on an empty stomach (no food should be consumed at least two hours before and for one hour after dosing). (druglib.com)
  • Recent studies have looked at whether drugs that block the growth of prostate cancer cells, such as abiraterone acetate, can improve how men do. (cochrane.org)
  • However, the role of miR-143 in the mediation of the sensitivity of prostate cancer cells to abiraterone acetate remains unrevealed. (jcancer.org)
  • Abiraterone Tablets Philippines works by blocking the production of androgens (male hormones) in the body, which can stimulate the growth of prostate cancer cells. (letsmeds.com)
  • To perform Concurrent process validation for Abiraterone Acetate Tablets USP 250 mg. (pharmacyjournal.info)
  • Process validation of abiraterone acetate tablets USP 250 MG . Int J Pharm Sci Drug Anal 2023;3(1):98-103. (pharmacyjournal.info)
  • 250 MG Abiraterone Acetate Tablets USP are formulated with the precise composition of ingredients. (arihantpharma.co.in)
  • ABT is an orally active acetate salt of the steroidal compound abiraterone with antiandrogen activity[ 3 ]. (ijpsonline.com)
  • Abiraterone (Abi) acetate is an ester prodrug of the anticancer agent Abiraterone, which shows IC 50 values of 15 nM and 2.5 nM for the 17,20-lyase and 17α-hydroxylase (CYP17 is a bifunctional enzyme with both 17α-hydroxylase and 17,20-lyase activity). (fluoroprobe.com)
  • Embryo-Fetal Toxicity: Abiraterone acetate can cause fetal harm. (nih.gov)
  • In females who are pregnant or planning to become pregnant, abiraterone 250 mg may cause fetal damage. (kegg-biotech.com)
  • Abiraterone acetate is a medication that blocks the effect of male sex hormones, and thereby, slows down prostate cancer growth. (cochrane.org)
  • You do not immediately quit taking abiraterone or your steroid medication. (chawlamedicos.com)
  • Abiraterone acetate tablets must be taken as a single dose once daily on an empty stomach. (nih.gov)
  • For patients with baseline moderate hepatic impairment (Child-Pugh Class B), reduce the abiraterone acetate tablets starting dose to 250 mg once daily. (nih.gov)
  • Overexpression of miR-143 promoted PC-AbiR sensitivity to abiraterone acetate in vitro and in vivo. (jcancer.org)
  • The Indian Pharma connects the buyer with the supplier who can ship ABIRAPRO(Abiraterone acetate 250 mg) to any country of the world as per the buyer's requirement and Government regulations of the country. (theindianpharma.com)
  • Abiraterone acetate has received Food and Drug Administration (FDA) (28 April 2011), European Medicines Agency (EMA) (23 September 2011), Medicines and Healthcare products Regulatory Agency (MHRA) (5 September 2011) and Therapeutic Goods Administration (TGA) (1 March 2012) approval for this indication. (wikipedia.org)
  • Abiraterone acetate was also licensed by the European Medicines Agency. (wikipedia.org)
  • Abiraterone is often used in men whose prostate cancer cannot be cured with surgery or other medicines. (chawlamedicos.com)
  • We included randomized trials, in which men diagnosed with hormone-sensitive prostate cancer were administered abiraterone acetate and prednisolone with ADT or ADT alone. (cochrane.org)
  • Abiraterone acetate was approved by the United States Food and Drug Administration on 28 April 2011 for mCRPC. (wikipedia.org)
  • Abiraterone Acetate Second-Line Treatment of Metastatic Castrate-Resistant Prostate Cancer (mCRPC) is. (oncozine.com)
  • Men with mCRPC were included if they had at least one pharmacy claim for enzalutamide or abiraterone (first claim date = index date) following surgical or medical castration, had no chemotherapy treatment within 12 months prior to the index date, and had continuous VHA enrollment for at least 12 months pre- and post-index date. (statinmed.com)
  • We identified 1229 men with mCRPC prescribed enzalutamide and 1945 prescribed abiraterone with mean ages of 74 and 73 years, respectively. (statinmed.com)
  • Enzalutamide-treated men with chemotherapy-naïve mCRPC had significantly lower resource utilization and healthcare costs compared with abiraterone-treated men. (statinmed.com)
  • The cost of Abiraterone Tablets Wholesale can vary depending on several factors, including the brand name, the strength of the tablets, and the country or region where it is being purchased. (letsmeds.com)
  • Abiraterone Acetate (ABT), the first compound through the inhibition of adrenal gland production of testosterone, increases the overall survival in Castrate-Resistant Prostate Cancer (CRPC) patients. (ijpsonline.com)
  • Finally, we showed that the combination of miR-143 and abiraterone acetate exerted the most profound tumor inhibition effect and prolonged the mice survival rate in PC3-AbiR tumor-bearing mice. (jcancer.org)
  • Significant inhibition of proliferation of the AR-positive prostate cancer cell lines LNCaP and VCaP with doses of Abiraterone ≥5 μM is confirmed [2] . (fluoroprobe.com)
  • Therefore it is hypothesized that the combination of enzalutamide, abiraterone acetate, dutasteride, and degarelix will result in near-complete AR inhibition and produce favorable pathologic changes after 12 weeks of therapy. (druglib.com)
  • It is important to discuss the risks and benefits of abiraterone with a healthcare professional to determine if it is the right treatment option for an individual patient's specific case. (letsmeds.com)
  • In addition, some healthcare systems or insurance plans may cover part or all of the cost of Abiraterone Tablets 500mg UAE for eligible patients. (letsmeds.com)
  • It is always a good idea to consult with a healthcare professional or pharmacist to get an accurate estimate of the cost of Abiraterone 500mg Tablets Online Saudi in a particular location. (letsmeds.com)
  • It is specifically a derivative of androstadienol with a pyridine ring attached at the C17 position and an acetate ester attached to the C3β hydroxyl group. (wikipedia.org)
  • Abiraterone acetate is the C3β acetate ester of abiraterone. (wikipedia.org)
  • Patients receiving abiraterone acetate tablets should also receive a gonadotropin-releasing hormone (GnRH) analog concurrently or should have had bilateral orchiectomy. (nih.gov)
  • For patients who develop hepatotoxicity during treatment, hold abiraterone acetate tablets until recovery. (nih.gov)
  • Abiraterone acetate tablets should be discontinued if patients develop severe hepatotoxicity. (nih.gov)
  • Upregulation of miR-143 may serve as a new strategy to enhance the therapeutical effect of abiraterone acetate on prostate cancer patients who are resistant to abiraterone acetate. (jcancer.org)
  • Mineralocorticoid excess is one of the main problems in patients taking Abiraterone Acetate. (theindianpharma.com)
  • Adding abiraterone acetate to hormone therapy improves overall survival but probably not quality of life. (cochrane.org)
  • Abiraterone and increased survival in metastatic prostate cancer. (zytigahcp.com)
  • CYP3A4 Inducers: Avoid concomitant strong CYP3A4 inducers during abiraterone acetate treatment. (nih.gov)
  • However, there is also an increase in severe and life-threatening side effects, likely leading to discontinued treatment, with the addition of abiraterone acetate. (cochrane.org)
  • it Contains Abiraterone Acetate which is one of the best medicine for Cancer Treatment. (kegg-biotech.com)
  • These measures are required during and for one week after treatment with abiraterone. (druglib.com)
  • Feng Y, Cao H, Zhao W, Chen L, Wang D, Gao R. miR-143 mediates abiraterone acetate resistance by regulating the JNK/Bcl-2 signaling pathway in prostate cancer. (jcancer.org)
  • The studies compared abiraterone acetate and hormone therapy to hormone therapy alone. (cochrane.org)
  • Abiraterone is an agent with an established role in that disease stage, which has only recently been evaluated in the hormone-sensitive setting. (cochrane.org)
  • To assess the effects of early abiraterone acetate, in combination with systemic ADT, for newly diagnosed metastatic hormone-sensitive prostate cancer. (cochrane.org)
  • Abiraterone 500mg Tablets Online is used to treat advanced or metastatic prostate cancer that has spread beyond the prostate gland and is no longer responsive to hormone therapy. (letsmeds.com)
  • Abiraterone is usually used in cases of prostate cancer where medical or surgical treatments that lower testosterone have not been sucessful and the cancer has spread to other parts of the body. (4nrx.md)
  • Abiraterone Acetate works by blocking the production of Testosterone and results in slowing down the spread and growth of cancerous tissue. (theindianpharma.com)
  • 0.0001) were significantly lower in the enzalutamide cohort compared with the abiraterone cohort. (statinmed.com)
  • The method will also suffice the suitability for the assay of abiraterone acetate in bulk and finished products. (ijpsonline.com)